Cited by 129Acute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationCancer Genomics and Diagnostics

Clonal hematopoiesis: Mutation-specific adaptation to environmental change

Open access
Florez, Marcus A., Tran, Brandon T., Wathan, Trisha K., DeGregori, James, Pietras, Eric M., King, Katherine Y.·2022·Cell Stem Cell

Abstract

Clonal hematopoiesis of indeterminate potential (CHIP) describes a widespread expansion of genetically variant hematopoietic cells that increases exponentially with age and is associated with increased risks of cancers, cardiovascular disease, and other maladies. Here, we discuss how environmental contexts associated with CHIP, such as old age, infections, chemotherapy, or cigarette smoking, alter tissue microenvironments to facilitate the selection and expansion of specific CHIP mutant clones. Further, we consider major remaining gaps in knowledge, including intrinsic effects, clone size thresholds, and factors affecting clonal competition, that will determine future application of this field in transplant and preventive medicine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.stem.2022.05.006

Cites

257 of 257 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Over a lifetime, repeated infections, autoimmune dysregulation, systemic disease that promotes inflammatory signals such as CVD, or other physiological stresses including metabolic stress or sleep deprivation may lead to systemic inflammation that provides cumulative, chronic positive selective pressure upon CH clones.

    “Over a lifetime of an organism, repeated infections, autoimmune dysregulation, systemic disease that promotes inflammatory signals such as CVD, or other physiological stresses including metabolic stress or sleep deprivation may lead to systemic inflammation that provides cumulative, chronic positive selective pressure upon CH clones [67].”

    From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [67]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 259 references couldn’t be matched to a known paper.

Research works printed but not linked: 5

  1. BICK AG, POPADIN K, THORBALL CW, UDDIN MM, ZANNI M, YU B, CAVASSINI M, RAUCH A, TARR P, SCHMID P, BERNASCONI E, GUNTHARD H, LIBBY P, BOERWINKLE E, MCLAREN P, BALLANTYNE CM, GRINSPOON SK, NATARAJAN P & FELLAY J 2020b. Increased CHIP Prevalence Amongst People Living with HIV. medRxiv.
  2. RODRIGUEZ-MEIRA A, NORFO R, WEN WX, CHÉDEVILLE AL, RAHMAN H, O’SULLIVAN J, WANG G, LOUKA E, KRETZSCHMAR WW, PATERSON A, BRIERLEY C, MARTIN J-E, DEMEULE C, BASHTON M, SOUSOS N, HAMBLIN A, GUERMOUCHE H, PASQUIER F, MARZAC C, GIRODON F, DRUMMOND M, HARRISON C, PLO I, JACOBSEN SEW, PSAILA B, THONGJUEA S, ANTONY-DEBRÉ I & MEAD AJ 2022. Deciphering TP53 mutant Cancer Evolution with Single-Cell Multi-Omics. bioRxiv, 2022.03.28.485984. PMC10484789 37666991
  3. STÖLZEL F, FORDHAM SE, LIN W-Y, BLAIR H, ELSTOB C, NANDANA D, MOHR B, RUHNKE L, KUNADT D, DILL C, ALLSOP D, PIDDOCK R, SOURA E-N, PARK C, FADLY M, RAHMAN T, ALHARBI A, WOBUS M, ALTMANN H, RÖLLIG C, WAGENFÜHR L, JONES GL, MENNE T, JACKSON GH, MARR HJ, FITZGIBBON J, ONEL K, MEGGENDORFER M, HEIDENREICH O, HAFERLACH T, VILLAR S, ARICETA B, DIAZ RA, PROSPER F, MONTESINOS P, MARTINEZ-LOPEZ J, BORNHÄUSER M & ALLAN JM 2021. Biallelic TET2 mutation sensitizes to 5’-azacitidine in acute myeloid leukemia. medRxiv. PMC9977313 36480300
  4. VAN DEUREN RC, ANDERSSON-ASSARSSON JC, KRISTENSSON FM, STEEHOUWER M, SJÖHOLM K, SVENSSON P-A, PIETERSE M, GILISSEN C, TAUBE M, JACOBSON P, PERKINS R, BRUNNER HG, NETEA MG, PELTONEN M, CARLSSON B, HOISCHEN A & CARLSSON LMS 2021. Expansion of mutation-driven haematopoietic clones is associated with insulin resistance and low HDL-cholesterol in individuals with obesity. bioRxiv, 2021.05.12.443095.
  5. WONG WJ, EMDIN C, BICK A, ZEKAVAT SM, NIROULA A, PIRRUCCELLO J, DICHTEL L, GRIFFIN G, UDDIN MM, GIBSON CJ, KOVALCIK V, LIN AE, MCCONKEY ME, VROMMAN A, SELLAR RS, KIM PG, AGRAWAL M, WEINSTOCK J, LONG MT, YU B, BANERJEE R, NICHOLLS RC, KELLY M, LOH P-R, MCCARROLL S, BOERWINKLE E, VASAN R, JAISWAL S, JOHNSON A, CHUNG RT, COREY K, LEVY D, BALLANTYNE C, GROUP, N. T. H. W., EBERT BL & NATARAJAN P 2022. Clonal hematopoiesis and risk of chronic liver disease. medRxiv, 2022.01.17.22269409.

Cited by

Sorted by citations

Authors
Florez, M. A., Tran, B. T., Wathan, T. K., DeGregori, J., Pietras, E. M., & King, K. Y.
Affiliations
  • Baylor College of Medicine (US)
  • University of Colorado Anschutz (US)
Corresponding author
King, Katherine Y.
Venue
Cell Stem Cell
Publisher
Elsevier BV
Published
2022-06
Volume
29
Issue
6
Pages
882-904
ISSN
  • 1875-9777 (ISSN-L)
  • 1934-5909
OpenAlex
W4281715700
Cited by
129
References
259
Citations by year
2026: 29 · 2025: 35 · 2024: 38 · 2023: 20 · 2022: 7
FWCI
4.46
Type
journal article
Language
en
Open access
Locations
  • Cell stem cell (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute on Aging (R01AG066544, R01AG067584)
  • National Heart, Lung, and Blood Institute (F31HL156500, R01HL134880, R01HL136333, R35HL155672)
  • National Cancer Institute (P01CA265748)
  • National Institute of Allergy and Infectious Diseases (R01AI141716)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK119394)
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
clonal hematopoiesis of indeterminate potential, clonal evolution, somatic mutations, hematopoietic stem cells, tissue microenvironment, aging, infection, chemotherapy, cigarette smoking, clonal competition, cancer risk, cardiovascular disease, hematopoietic stem cell transplantation
MeSH terms
Clonal Hematopoiesis, Hematopoiesis, Hematopoietic Stem Cells, Mutation, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review